BRKR Bruker Corporation
Healthcare$46.92+2.69%ClosedMarket Cap: $7.14B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$50.13
Target (Median)
$51.50
Target Range
$35.00 - $60.00
Upside from current price: 6.8%
Rating Distribution
2 Strong Buy7 Buy4 Hold1 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-07 | UBS | maintain | Neutral | Neutral |
| 2026-05-07 | Citigroup | maintain | Neutral | Neutral |
| 2026-05-07 | Barclays | maintain | Overweight | Overweight |
| 2026-05-07 | TD Cowen | maintain | Hold | Hold |
| 2026-03-30 | Guggenheim | maintain | Buy | Buy |
| 2026-02-13 | TD Cowen | maintain | Hold | Hold |
| 2026-02-13 | Goldman Sachs | maintain | Sell | Sell |
| 2026-02-13 | Barclays | maintain | Overweight | Overweight |
| 2026-02-13 | Citigroup | maintain | Neutral | Neutral |
| 2026-01-26 | Guggenheim | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $2.42 | $3.74B | 6 |
| Sun Dec 31 | $2.78 | $3.95B | 1 |
| Mon Dec 31 | $3.14 | $4.20B | 1 |
| Tue Dec 31 | $3.43 | $4.28B | 1 |